Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

TOKYO-172

Alternative Names: tokyo-172, tokyo172, tokyo 172
Latest Update: 2024-05-03
Latest Update Note: Clinical Trial Update

Product Description

For Bladder Urothelial Carcinoma (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03091660)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Henry M. Jackson Foundation for the Advancement of Military Medicine
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Communicable Diseases|Latent Tuberculosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
TIPI

P3

Recruiting

Communicable Diseases|Latent Tuberculosis

2027-09-30

Recent News Events

Date

Type

Title

12/15/2023

PubMed

 The safety of BCG revaccination in the context of COVID-19.

11/24/2023

PubMed

 Validation of the ^{10}Be Ground-State Molecular Structure Using ^{10}Be(p,pα)^{6}He Triple Differential Reaction Cross-Section Measurements.

04/28/2023

PubMed

 Multiple Mechanisms in Proton-Induced Nucleon Removal at ∼100  MeV/Nucleon.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions